[ad_1] New Delhi: The Prime Minister’s Office (PMO) has directed the Ministry of Micro, Small and Medium Enterprises to take necessary steps after representatives from the pharmaceutical industry warned that stringent regulatory action over quality issues could cause serious disruptions, leading to shortages of critical medicines of mass use such antibiotics, anti-diabetics and oncology drugs….
[ad_1] India’s drug regulator plans to ease processes, set fixed approval timelines and explore artificial intelligence to improve execution, its chief said on Thursday. “We’re trying to increase our efficiency, cutting down on regulations so that we create more and more resources within our system,” the Central Drugs Standard Control Organisation‘s Rajeev Raghuvanshi said in…
[ad_1] India targets new markets for pharma export growth amid US tariffs concerns We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link